Related Experiment Video

Updated: Aug 17, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Amyloid associated proteins in Alzheimer's and prion disease

R Veerhuis1, R S Boshuizen, A Familian

  • 1Institute for Clinical and Experimental Neurosciences-VU, Departments of Psychiatry Vrije Universiteit University Medical Center, 1007 MB Amsterdam, The Netherlands. r.veerhuis@vumc.nl

Current Drug Targets. CNS and Neurological Disorders
|June 25, 2005
PubMed

Insights

Amyloid-associated factors influence microglial activation in neurodegenerative diseases like Alzheimer's. Understanding these factors is key to developing therapies that target amyloid accumulation and glial activation.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglial activation and inflammation are hallmarks of Alzheimer's disease (AD) and prion diseases.
  • Amyloid deposits in AD and prion diseases contain activated glial cells and amyloid-associated factors.
  • Pro-inflammatory cytokines from microglia are implicated as drivers of AD pathology.

Purpose of the Study:

  • To review the dual role of amyloid-associated factors in amyloid peptide fibril formation.
  • To discuss the impact of these factors on microglia activation in the context of neurodegeneration.
  • To highlight the potential for therapeutic strategies targeting amyloid and glial activation.

Main Methods:

  • Literature review of studies on amyloid-associated factors, microglial activation, and neurodegenerative diseases.
  • Analysis of the relationship between amyloid peptide fibril formation and glial cell responses.
  • Synthesis of information on the mechanisms underlying amyloid-associated factor influence.

Main Results:

  • Amyloid-associated factors modulate the fibrillogenic properties of amyloid peptides (Abeta and PrP).
  • These factors can either promote or inhibit amyloid formation, influencing its toxicity.
  • Factors enhancing fibril formation may sequester toxic oligomers, potentially protecting neurons.

Conclusions:

  • Amyloid-associated factors play a complex role in neurodegenerative diseases by influencing both amyloid aggregation and neuroinflammation.
  • Targeting these factors offers a promising therapeutic avenue for diseases characterized by amyloid accumulation and glial activation.
  • Further research into these mechanisms can guide the development of novel treatments for AD and related disorders.

More Related Videos

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster10:26

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

Published on: March 12, 2018

Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli09:43

Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli

Published on: December 19, 2015

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...